My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 234

    1.

    Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

    D'Agostino RB Jr, Hamman RF, Karter AJ, Mykkanen L, Wagenknecht LE, Haffner SM; Insulin Resistance Atherosclerosis Study Investigators.

    Diabetes Care. 2004 Sep;27(9):2234-40.PMID: 15333490 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

    Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study.

    Diabetes. 2002 Apr;51(4):1131-7.PMID: 11916936 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.

    Hanley AJ, D'Agostino R Jr, Wagenknecht LE, Saad MF, Savage PJ, Bergman R, Haffner SM; Insluin Resistance Atrherosclerosis Study.

    Diabetes. 2002 Apr;51(4):1263-70.PMID: 11916954 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.

    Haffner SM, D'Agostino R Jr, Mykkänen L, Tracy R, Howard B, Rewers M, Selby J, Savage PJ, Saad MF.

    Diabetes Care. 1999 Apr;22(4):562-8.PMID: 10189532 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.

    Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, Zinman B, Haffner SM; insulin resistance atherosclerosis study.

    Diabetes. 2004 Oct;53(10):2623-32.PMID: 15448093 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.

    Hanley AJ, Festa A, D'Agostino RB Jr, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF, Haffner SM.

    Diabetes. 2004 Jul;53(7):1773-81.PMID: 15220201 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

    Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M.

    Diabetes Care. 2002 Jul;25(7):1135-41.PMID: 12087010 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Relationship between insulin resistance and risk factors for cardiovascular disease in Japanese non-insulin-dependent diabetic patients.

    Wasada T, Kuroki H, Arii H, Maruyama A, Aoki K, Katsumori K, Saito S, Hanada H, Omori Y.

    Diabetes Res Clin Pract. 1994 Oct;25(3):191-8.PMID: 7851274 [PubMed - indexed for MEDLINE]Related articles

    9.

    Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.

    Hanley AJ, Williams K, Stern MP, Haffner SM.

    Diabetes Care. 2002 Jul;25(7):1177-84.PMID: 12087016 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study.

    Bell RA, Mayer-Davis EJ, Martin MA, D'Agostino RB Jr, Haffner SM.

    Diabetes Care. 2000 Nov;23(11):1630-6.PMID: 11092284 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?

    Haffner SM, D'Agostino R Jr, Festa A, Bergman RN, Mykkänen L, Karter A, Saad MF, Wagenknecht LE.

    Diabetes Care. 2003 Oct;26(10):2796-803.PMID: 14514582 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association.

    De Cosmo S, Minenna A, Ludovico O, Mastroianno S, Di Giorgio A, Pirro L, Trischitta V.

    Diabetes Care. 2005 Apr;28(4):910-5.PMID: 15793194 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.

    Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW.

    Diabetes Care. 2007 May;30(5):1219-25. Epub 2007 Jan 26.PMID: 17259468 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

    Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N.

    Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):334-9.PMID: 15977101 [PubMed - indexed for MEDLINE]Related articles

    15.

    Vitamin C intake and cardiovascular disease risk factors in persons with non-insulin-dependent diabetes mellitus. From the Insulin Resistance Atherosclerosis Study and the San Luis Valley Diabetes Study.

    Mayer-Davis EJ, Monaco JH, Marshall JA, Rushing J, Juhaeri.

    Prev Med. 1997 May-Jun;26(3):277-83.PMID: 9144749 [PubMed - indexed for MEDLINE]Related articles

    16.

    High normal 2-hour plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes.

    Piché ME, Lemieux S, Pérusse L, Weisnagel SJ.

    Diabetologia. 2005 Apr;48(4):732-40. Epub 2005 Mar 12.PMID: 15765221 [PubMed - indexed for MEDLINE]Related articles

    17.

    Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.

    Festa A, Williams K, Hanley AJ, Haffner SM.

    Diabetes. 2008 Jun;57(6):1638-44. Epub 2008 Mar 10.PMID: 18332099 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.

    da Silva RC, Miranda WL, Chacra AR, Dib SA.

    J Diabetes Complications. 2007 Mar-Apr;21(2):84-92.PMID: 17331856 [PubMed - indexed for MEDLINE]Related articles

    19.

    Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.

    Festa A, Williams K, Tracy RP, Wagenknecht LE, Haffner SM.

    Circulation. 2006 Apr 11;113(14):1753-9. Epub 2006 Apr 3.PMID: 16585388 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.

    Festa A, Williams K, Hanley AJ, Otvos JD, Goff DC, Wagenknecht LE, Haffner SM.

    Circulation. 2005 Jun 28;111(25):3465-72.PMID: 15983261 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity